Malin Corporation | MLC - Current Liabilities

Stock Price
7.60
Daily Change
0 0%
Monthly
0%
Yearly
-24.00%
Q1 Forecast
7.37

Malin Corporation reported EUR1000K in Current Liabilities for its fiscal semester ending in December of 2024.





Current Liabilities Change Date
Akebia Therapeutics USD 162.94M 29.56M Dec/2025
Alaunos Therapeutics USD 921K 153K Sep/2025
ALKERMES USD 543.44M 69.08M Dec/2025
Avita Medical AUD 62.68M 77K Dec/2025
Dianthus Therapeutics USD 30.73M 6.88M Dec/2025
Eurofins Scientific SE EUR 2.43B 344.6M Dec/2025
Ionis Pharmaceuticals USD 783M 120.46M Dec/2025
IQVIA Holdings USD 8.34B 170M Dec/2025
Lonza CHF 3.58B 970M Dec/2024
Malin Corporation EUR 1000K 500K Dec/2024
Moderna USD 1.99B 306M Dec/2025
Organon & Co USD 2.68B 117M Sep/2025
Ovoca Bio EUR 2.44M 1.1M Jun/2022
Revvity USD 1.33B 108.5M Dec/2025
Tectonic Therapeutic USD 9.37M 1.99M Sep/2025
Viatris USD 7.09B 269.8M Dec/2025
Xeris Pharmaceuticals USD 116.2M 21.03M Sep/2025